These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 5978530

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Antimitotic effect of podophyllin derivatives on genital cancers].
    Stamm O.
    Bull Soc R Belge Gynecol Obstet; 1965; 35(4):287-90. PubMed ID: 5856818
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Clinical experiences with SP-I].
    Furue H, Koizumi H, Nishi I, Hattori T, Yokoyama T.
    Gan No Rinsho; 1967 Sep; 13(9):658-62. PubMed ID: 5627165
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Apropos of a case of carcinoma of the ovary].
    Clerc JP.
    Gynaecologia; 1968 Sep; 165(2):77-8. PubMed ID: 5703823
    [No Abstract] [Full Text] [Related]

  • 28. Podophyllin and the mouse cervix: assessment of carcinogenic potential.
    Kaminetzky HA, Swerdlow M.
    Am J Obstet Gynecol; 1965 Oct 15; 93(4):486-90. PubMed ID: 5841727
    [No Abstract] [Full Text] [Related]

  • 29. [Morphological and functional alterations of the blood cell system of guinea pigs after treatment with cytostatic agents, prednisolone and phenylbutazone. I. Alterations of different leukocyte and lymphocyte subgroups in the blood].
    Schick P, Trepel F, Begemann H.
    Z Gesamte Exp Med Einschl Exp Chir; 1968 Oct 15; 148(4):275-305. PubMed ID: 4179315
    [No Abstract] [Full Text] [Related]

  • 30. [Prevention of experimental arthritis with the cytostatic agent podophyllinic acid ethylhydrazide].
    Szántó L, Lörincz G, Gömör B.
    Arzneimittelforschung; 1968 Jul 15; 18(7):886-9. PubMed ID: 5756046
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Submicroscopic changes in human cancer cells under the effect of SP-I and SP-G "Sandoz"].
    Sipus N, Padovan I, Lipozencić M.
    Oncology; 1966 Jul 15; 20(4):276-90. PubMed ID: 5958475
    [No Abstract] [Full Text] [Related]

  • 35. Analysis of the results of regional chemotherapy for carcinomas of the orofacial region.
    Bilder J, Hornová J.
    Neoplasma; 1970 Jul 15; 17(1):85-92. PubMed ID: 5447247
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of podophyllum products S.P.I.&S.P.G. on malignant diseases.
    Datta H, Biswas S.
    Indian J Cancer; 1968 Jun 15; 5(2):152-9. PubMed ID: 5688054
    [No Abstract] [Full Text] [Related]

  • 38. [Tumor-specific effects of substances of the podophyllotoxin and Verrucaria series on the chorioallantoic membrane tumor system].
    Rauen HM, Norpoth K.
    Arzneimittelforschung; 1966 Dec 15; 16(12):1594-600. PubMed ID: 6014933
    [No Abstract] [Full Text] [Related]

  • 39. [Considerations on the use of Proresid (SPI-SPG Sandoz) as an adjuvant in the treatment of tumors (preliminart communication)].
    Motti VJ.
    Hospital (Rio J); 1968 Oct 15; 74(4):1377-88. PubMed ID: 5304166
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.